Nexuspiral Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Nexuspiral General Information

Description

Developer of a genome editing technology intended to treat genetic diseases. The company's technology is developing a novel genome design technology that utilizes single-strand oligonucleotides to repair the mutation of the genes responsible for rare genetic diseases, enabling patients to get treatment for specific ailments.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 56 Naniwamachi
  • Hyogo Entrepreneurship Plaza Hyogo Prefecture
  • Kobe, Chuo-ku 650-0035
  • Japan
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Decision/Risk Analysis
Vertical(s)
Corporate Office
  • 56 Naniwamachi
  • Hyogo Entrepreneurship Plaza Hyogo Prefecture
  • Kobe, Chuo-ku 650-0035
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nexuspiral Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 28-Aug-2024 Completed Out of Business
5. Accelerator/Incubator 15-Sep-2022 Completed Generating Revenue
4. Accelerator/Incubator 17-Feb-2022 Completed Generating Revenue
3. Seed Round 01-Sep-2021 Completed Generating Revenue
2. Grant $227K Completed Generating Revenue
1. Grant 27-Aug-2020 $283K Completed Generating Revenue
To view Nexuspiral’s complete valuation and funding history, request access »

Nexuspiral Patents

Nexuspiral Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3498837-A1 Genome editing method Inactive 12-Aug-2016
EP-3498837-A4 Genome editing method Inactive 12-Aug-2016
EP-4056701-A1 Genome editing method Inactive 12-Aug-2016
JP-2021151246-A Genome editing method Active 12-Aug-2016
JP-2022023037-A Genome editing method Active 12-Aug-2016 C12N15/902
To view Nexuspiral’s complete patent history, request access »

Nexuspiral FAQs

  • When was Nexuspiral founded?

    Nexuspiral was founded in 2019.

  • Where is Nexuspiral headquartered?

    Nexuspiral is headquartered in Kobe, Japan.

  • What industry is Nexuspiral in?

    Nexuspiral’s primary industry is Drug Discovery.

  • Is Nexuspiral a private or public company?

    Nexuspiral is a Private company.

  • What is Nexuspiral’s current revenue?

    The current revenue for Nexuspiral is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process